Stressful events during pregnancy adversely affect brain development and may increase the risk of psychiatric disorders later in life. Early changes in the kynurenine (KYN) pathway (KP) of tryptophan (TRP) degradation, which contains several neuroactive metabolites, including kynurenic acid (KYNA), 3-hydroxykynurenine (3-HK), and quinolinic acid (QUIN), may constitute a molecular link between prenatal stress and delayed pathological consequences. To begin testing this hypothesis experimentally, we examined the effects of a 2-h restraint stress on KP metabolism in pregnant FVB/N mice on gestational day 17. TRP, KYN, KYNA, 3-HK, and QUIN levels were measured in maternal and fetal plasma and brain, as well as in the placenta, immediately after stress termination and 2 h later. In the same animals, we determined the activity of TRP 2,3-dioxygenase (TDO) in the maternal liver and in the placenta. Compared to unstressed controls, mostly transient changes in KP metabolism were observed in all of the tissues examined. Specifically, stress caused significant elevations of KYNA levels in the maternal plasma, placenta, and fetal brain, and also resulted in increased levels of TRP and KYN in the placenta, fetal plasma, and fetal brain. In contrast, 3-HK and QUIN levels remained unchanged from control values in all tissues at any time point. In the maternal liver, TDO activity was increased 2 h after stress cessation. Taken together, these findings indicate that an acute stress during the late gestational period preferentially affects the KYNA branch of KP metabolism in the fetal brain. Possible long-term consequences for postnatal brain development and pathology remain to be examined.

1.
Maccari S, Darnaudery M, Morley-Fletcher S, Zuena AR, Cinque C, Van Reeth O: Prenatal stress and long-term consequences: implications of glucocorticoid hormones. Neurosci Biobehav Rev 2003;27:119-127.
2.
Glover V, O'Connor TG, O'Donnell K: Prenatal stress and the programming of the HPA axis. Neurosci Biobehav Rev 2010;35:17-22.
3.
Li J, Olsen J, Vestergaard M, Obel C: Attention-deficit/hyperactivity disorder in the offspring following prenatal maternal bereavement: a nationwide follow-up study in Denmark. Eur Child Adolesc Psychiatry 2010;19:747-753.
4.
Talge NM, Neal C, Glover V, Early Stress TR, Prevention Science Network F, Neonatal Experience on C, Adolescent Mental H: Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007;48:245-261.
5.
Brown AS: The environment and susceptibility to schizophrenia. Prog Neurobiol 2011;93:23-58.
6.
Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, Kenny LC, Mortensen PB: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry 2008;65:146-152.
7.
Maccari S, Darnaudery M, van Reeth O: Hormonal and behavioural abnormalities induced by stress in utero: an animal model for depression. Stress 2001;4:169-181.
8.
Dong E, Dzitoyeva SG, Matrisciano F, Tueting P, Grayson DR, Guidotti A: Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice. Biol Psychiatry 2015;77:589-596.
9.
Wei L, Hao J, Lacher RK, Abbott T, Chung L, Colangelo CM, Kaffman A: Early-life stress perturbs key cellular programs in the developing mouse hippocampus. Dev Neurosci 2015;37:476-488.
10.
Diz-Chaves Y, Astiz M, Bellini MJ, Garcia-Segura LM: Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice. Brain Behav Immun 2013;28:196-206.
11.
Diz-Chaves Y, Pernia O, Carrero P, Garcia-Segura LM: Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J Neuroinflammation 2012;9:71.
12.
Vanbesien-Mailliot CC, Wolowczuk I, Mairesse J, Viltart O, Delacre M, Khalife J, Chartier-Harlin MC, Maccari S: Prenatal stress has pro-inflammatory consequences on the immune system in adult rats. Psychoneuroendocrinology 2007;32:114-124.
13.
Moroni F, Cozzi A, Sili M, Mannaioni G: Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. J Neural Transm (Vienna) 2012;119:133-139.
14.
Stone TW, Stoy N, Darlington LG: An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol Sci 2013;34:136-143.
15.
Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ: Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 2012;13:465-477.
16.
Hayaishi O, Rothberg S, Mehler AH, Saito Y: Studies on oxygenases; enzymatic formation of kynurenine from tryptophan. J Biol Chem 1957;229:889-896.
17.
Pawlak D, Takada Y, Urano T, Takada A: Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res Bull 2000;52:197-205.
18.
Gibney SM, Fagan EM, Waldron AM, O'Byrne J, Connor TJ, Harkin A: Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. Int J Neuropsychopharmacol 2014;17:917-928.
19.
Miura H, Ozaki N, Shirokawa T, Isobe K: Changes in brain tryptophan metabolism elicited by ageing, social environment, and psychological stress in mice. Stress 2008;11:160-169.
20.
Curzon G, Green AR: Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol 1969;37:689-697.
21.
Lupien SJ, McEwen BS, Gunnar MR, Heim C: Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009;10:434-445.
22.
McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, Nasca C: Mechanisms of stress in the brain. Nat Neurosci 2015;18:1353-1363.
23.
Notarangelo FM, Pocivavsek A: Elevated kynurenine pathway metabolism during neurodevelopment: implications for brain and behavior. Neuropharmacology 2017;112:275-285.
24.
Pocivavsek A, Notarangelo FM, Wu HQ, Bruno JP, Schwarcz R: Astrocytes as pharmacological targets in the treatment of schizophrenia: focus on kynurenic acid; in Pletnikov M, Waddington J (eds): Modeling the Psychopathological Dimensions of Schizophrenia. San Diego, Elsevier, 2015, pp 423-443.
25.
Babenko O, Kovalchuk I, Metz GA: Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev 2015;48:70-91.
26.
Bock J, Wainstock T, Braun K, Segal M: Stress in utero: prenatal programming of brain plasticity and cognition. Biol Psychiatry 2015;78:315-326.
27.
Nilsen RM, Bjorke-Monsen AL, Midttun O, Nygard O, Pedersen ER, Ulvik A, Magnus P, Gjessing HK, Vollset SE, Ueland PM: Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstet Gynecol 2012;119:1243-1250.
28.
Erisman S, Carnes M, Takahashi LK, Lent SJ: The effects of stress on plasma ACTH and corticosterone in young and aging pregnant rats and their fetuses. Life Sci 1990;47:1527-1533.
29.
Bingham BC, Sheela Rani CS, Frazer A, Strong R, Morilak DA: Exogenous prenatal corticosterone exposure mimics the effects of prenatal stress on adult brain stress response systems and fear extinction behavior. Psychoneuroendocrinology 2013;38:2746-2757.
30.
Nemeth S, Vigas M: Adrenal hormones and increase of liver tyrosine aminotransferase and tryptophan pyrrolase activity after immobilization in rats. Endocrinol Exp 1975;9:100-104.
31.
Green AR, Curzon G: Effects of hydrocortisone and immobilization on tryptophan metabolism in brain and liver of rats of different ages. Biochem Pharmacol 1975;24:713-716.
32.
Manuelpillai U, Ligam P, Smythe G, Wallace EM, Hirst J, Walker DW: Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: up-regulation by inflammatory stimuli and with clinical infection. Am J Obstet Gynecol 2005;192:280-288.
33.
Suzuki S, Tone S, Takikawa O, Kubo T, Kohno I, Minatogawa Y: Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J 2001;355:425-429.
34.
Roper MD, Franz JM: Glucocorticoid control of the development of tryptophan oxygenase in the young rat. J Biol Chem 1977;252:4354-4360.
35.
Zorn AM: Liver development. StemBook DOI: 10.3824/stembook.1.25.1.
36.
Curzon G, Joseph MH, Knott PJ: Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem 1972;19:1967-1974.
37.
Nemeth S: The effect of stress on the activity of hepatic tryptophan pyrrolase, of tyrosine aminotransferase in various organs and on the level of tryptophan in the liver and plasma of rats. Physiol Bohemoslov 1977;26:557-563.
38.
Peters DA: Maternal stress increases fetal brain and neonatal cerebral cortex 5-hydroxytryptamine synthesis in rats: a possible mechanism by which stress influences brain development. Pharmacol Biochem Behav 1990;35:943-947.
39.
Sedlmayr P, Blaschitz A, Stocker R: The role of placental tryptophan catabolism. Front Immunol 2014;5:230.
40.
Braidman IP, Rose DP: Inhibition of tryptophan oxygenase in rat liver by steroid hormones. Biochem J 1970;118:7P-8P.
41.
Badawy AA: Effects of pregnancy on tryptophan metabolism and disposition in the rat. Biochem J 1988;255:369-372.
42.
Badawy AA: Tryptophan metabolism, disposition and utilization in pregnancy. Biosci Rep 2015;35:e00261.
43.
Rennie MY, Mu J, Rahman A, Qu D, Whiteley KJ, Sled JG, Adamson SL: The Ultraplacental, Fetoplacental, and Yolk Sac Circulation in the Mouse. San Diego, Elsevier, 2014, pp 201-210.
44.
Myatt L: Placental adaptive responses and fetal programming. J Physiol 2006;572:25-30.
45.
Hsiao EY, Patterson PH: Placental regulation of maternal-fetal interactions and brain development. Dev Neurobiol 2012;72:1317-1326.
46.
Bronson SL, Bale TL: Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology 2014;155:2635-2646.
47.
O'Donnell K, O'Connor TG, Glover V: Prenatal stress and neurodevelopment of the child: focus on the HPA axis and role of the placenta. Dev Neurosci 2009;31:285-292.
48.
Moe AJ: Placental amino acid transport. Am J Physiol 1995;268:C1321-C1331.
49.
Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, Blakely RD, Deneris ES, Levitt P: A transient placental source of serotonin for the fetal forebrain. Nature 2011;472:347-350.
50.
Ligam P, Manuelpillai U, Wallace EM, Walker D: Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. Placenta 2005;26:498-504.
51.
Nicholls T, Nitsos I, Smythe G, Walker DW: Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas. Am J Obstet Gynecol 2001;185:988-995.
52.
Beggiato S, Sathyasaikumar KV, Notarangelo FM, Giorgini F, Muchowski PJ, Schwarcz R: Prenatal kynurenine treatment in mice: effects on placental and fetal brain kynurenines. Soc Neurosci Abstr 2014;39:51.05.
53.
Notarangelo FM, Schwarcz R: Prenatal LPS exposure preferentially increases kynurenine pathway metabolism in the fetal brain. Soc Neurosci Abstr 2015;40:74.02.
54.
Sano M, Ferchaud-Roucher V, Kaeffer B, Poupeau G, Castellano B, Darmaun D: Maternal and fetal tryptophan metabolism in gestating rats: effects of intrauterine growth restriction. Amino Acids 2016;48:281-290.
55.
Notarangelo FM, Goeden N, Pocivavsek A, Beggiato S, Wons K, Bonnin A, Schwarcz R: Kynurenic acid in the fetal mouse brain: on the role of mother-placenta-fetus dynamics. Soc Neurosci Abstr 2016;41:845.29.
56.
Ceresoli-Borroni G, Schwarcz R: Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain. Amino Acids 2000;19:311-323.
57.
Beggiato S, Notarangelo FM, Schwarcz R: Maternal, placental and fetal KYNA production in mouse tissue slices. Soc Neurosci Abstr 2015;40:48.19.
58.
Schlotz W, Phillips DI: Fetal origins of mental health: evidence and mechanisms. Brain Behav Immun 2009;23:905-916.
59.
Jansson LC, Akerman KE: The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells. J Neural Transm (Vienna) 2014;121:819-836.
60.
Lozada AF, Wang X, Gounko NV, Massey KA, Duan J, Liu Z, Berg DK: Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors. J Neurosci 2012;32:7651-7661.
61.
Ceresoli-Borroni G, Guidetti P, Amori L, Pellicciari R, Schwarcz R: Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications. J Neurosci Res 2007;85:845-854.
62.
Alexander KS, Pocivavsek A, Wu HQ, Pershing ML, Schwarcz R, Bruno JP: Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine. Neuroscience 2013;238:19-28.
63.
Forrest CM, Khalil OS, Pisar M, McNair K, Kornisiuk E, Snitcofsky M, Gonzalez N, Jerusalinsky D, Darlington LG, Stone TW: Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway. Neuroscience 2013;254:241-259.
64.
Forrest CM, McNair K, Pisar M, Khalil OS, Darlington LG, Stone TW: Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine. Neuroscience 2015;310:91-105.
65.
Khalil OS, Pisar M, Forrest CM, Vincenten MC, Darlington LG, Stone TW: Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring. Eur J Neurosci 2014;39:1558-1571.
66.
Pershing ML, Bortz DM, Pocivavsek A, Fredericks PJ, Jorgensen CV, Vunck SA, Leuner B, Schwarcz R, Bruno JP: Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology 2015;90:33-41.
67.
Pocivavsek A, Thomas MA, Elmer GI, Bruno JP, Schwarcz R: Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharmacology (Berlin) 2014;231:2799-2809.
68.
Schulz KM, Andrud KM, Burke MB, Pearson JN, Kreisler AD, Stevens KE, Leonard S, Adams CE: The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspring. Dev Neurobiol 2013;73:806-814.
69.
Baier CJ, Pallares ME, Adrover E, Monteleone MC, Brocco MA, Barrantes FJ, Antonelli MC: Prenatal restraint stress decreases the expression of alpha-7 nicotinic receptor in the brain of adult rat offspring. Stress 2015;18:435-445.
70.
Stevens KE, Adams CE, Yonchek J, Hickel C, Danielson J, Kisley MA: Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline. Psychopharmacology (Berlin) 2008;198:413-420.
71.
Ricceri L, De Filippis B, Fuso A, Laviola G: Cholinergic hypofunction in MeCP2-308 mice: beneficial neurobehavioural effects of neonatal choline supplementation. Behav Brain Res 2011;221:623-629.
72.
Langley EA, Krykbaeva M, Blusztajn JK, Mellott TJ: High maternal choline consumption during pregnancy and nursing alleviates deficits in social interaction and improves anxiety-like behaviors in the BTBR T + Itpr3tf/J mouse model of autism. Behav Brain Res 2015;278:210-220.
73.
Fineberg AM, Ellman LM: Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry 2013;73:951-966.
74.
Zavitsanou K, Lim CK, Purves-Tyson T, Karl T, Kassiou M, Banister SD, Guillemin GJ, Weickert CS: Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition. Brain Behav Immun 2014;41:173-181.
75.
Schröcksnadel K, Widner B, Bergant A, Neurauter G, Schennach H, Schröcksnadel H, Fuchs D: Longitudinal study of tryptophan degradation during and after pregnancy. Life Sci 2003;72:785-793.
76.
Notarangelo FM, Wu HQ, Macherone A, Graham DR, Schwarcz R: Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain. Anal Biochem 2012;421:573-581.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.